Our ESG commitment

ESG responsibilities are core to GreenLight Bio’s purpose

We harness the power of biology to meet the needs of growers, animals, and the planet. Our investors, partners, and team share this purpose and are committed to delivering benefits and returns that are sustainable over the long term.

We are a team dedicated to solving some of the world’s most pressing agricultural challenges by unlocking the full potential of RNA through our innovative platform and products. Given the scale and urgency of these challenges, we believe this approach is both responsible and rewarding.

Our products are designed to address critical needs in food safety and food security by enabling more sustainable agricultural production. We develop highly selective RNA‑based bio‑fungicides and bio‑insecticides that provide effective pest and disease control while maintaining a favorable environmental safety profile. These solutions are designed to meet the needs of growers and consumers alike, supporting productivity, resilience, and environmental stewardship.

Our agricultural and animal health product pipeline is powered by a proprietary development process and platform that enables the rapid, scalable, and cost‑effective design and manufacture of RNA‑based products. This capability allows us to bring RNA solutions to market efficiently and at the scale required to make a meaningful impact.

GreenLight Bio’s product pipeline for agriculture, and animal health is powered by a development process and proprietary platform that allows us to design and manufacture RNA-based products at a broad range of scales in a fast and cost-effective manner, making these solutions rapidly accessible.

We believe in doing the right thing to meet our environmental, social, and governance responsibilities.

As a public benefit corporation, we are structured and governed to prioritize our community, employees, partners, and society generally, as well as shareholders.

Underlying everything we do as a publicly traded public benefit corporation is a commitment to Environmental, Social, and Governance responsibilities. GreenLight Bio supports the Sustainable Development Goals (SDGs).

Environment

• We are propelling the revolution of offering alternatives to chemical pesticides by giving farmers access to RNA-based products that can effectively protect the food supply and surrounding biodiversity.
• Our agricultural products degrade quickly in the environment without detrimental impact to the soil, water, or the ecosystems dependent upon them.
• We design solutions to target only the pest that the farmer needs to control  without harming other organisms, particularly beneficial insects and pollinators, such as honeybees
• We aim to provide effective bio-control of the microorganisms responsible for crop losses, estimated at around 30% of the world’s food supply, by developing a control for fungal pathogens.
• We have developed a RNA solutions to protect honeybees from the Varroa destructor mite. Honeybees are responsible for the pollination of more than a third of all the food we eat and a little more than 80% of the fruits, vegetables, and tree nuts crucial to feeding the planet nutritiously.

How we operate in a sustainable manner:

• The RNA we use for our agricultural products has been produced with yeast recycled from the agriculture and food industries, using our proprietary technology.
• We will be analyzing our policies on waste management, energy consumption, and internal operations to ensure we operate as a company aligned with our goal of protecting humans, animals, and the environment.

Social

To address unmet agricultural needs in underserved farming communities, we work globally to advance the discovery, development, scale‑up, and manufacture of innovative crop protection solutions. Our goal is to ensure that RNA‑based technologies are deployed where they can have the greatest impact on food security, farmer livelihoods, and environmental sustainability.

In our plant health development process, we are committed to engaging early and consistently with local regulatory agencies, agricultural partners, and academic institutions. This collaborative approach allows us to design solutions tailored to regional crops and the pests and diseases that most directly affect them.

We aim to make RNA‑based agricultural products more accessible to low‑ and middle‑income countries, and we believe local challenges are best addressed through partnerships that begin at the earliest stages of research and development. By working alongside regional experts, we ensure our solutions are practical, effective, and aligned with local agronomic conditions.

To support this effort, we are establishing a global network of partnerships and workforce development initiatives to advance both research and manufacturing capabilities. Through collaborations with academic institutions, public research organizations, and local companies across Africa, Asia, and Latin America, we seek to build local capacity to research, develop, manufacture, and ultimately commercialize effective and selective RNA‑based solutions that target locally prevalent pests.

Together, these partnerships enable a more resilient and inclusive approach to crop protection—one that strengthens local innovation ecosystems while supporting sustainable agricultural productivity worldwide.

We continuously work to improve our representation of gender, race, and ethnicity at all levels, including our board, VP, and executive levels, and our efforts to date include:

• As of March 2022, 45% of our full-time employees self-identify as female and 45% of full-time employees self-identify as a non-Caucasian racial or ethnic group.
• 50% of our Executive team members and Senior Vice Presidents are female.
• 40% of our Executive team identifies as a non-Caucasian racial or ethnic group (Black or African American, Hispanic or Latino, American Indian or Alaska Native, Asian or Native Hawaiian, other Pacific Islander, or two or more races or ethnic groups).
• Women make up 40% of the C-Suite at GreenLight compared to the industry average of 24%

• We regularly measure and share with employees information about our gender pay gap and company statistics.
• Our employee-run resources groups focus on common priorities and areas of interest, including the LGBTQ+ community, women, community service and fundraising, wellness, and equity, diversity & inclusion.
• The growth in representation of female and racial and ethnic minority employees at GreenLight has outpaced our overall employee population growth; our employee base has increased 61% since March 2021, whereas there was a 66% and 80% increase in representation of women and ethnic and racial minorities, respectively.
• 46% of our employees in Research and Scientist positions are female, when women make up only 28% of the STEM workforce.

Governance

• GreenLight Bio operates as a public benefit corporation (PBC), a structure that formally embeds our commitment to delivering positive outcomes for communities, employees, partners, and society, in addition to generating sustainable value for shareholders.
• GreenLight Bio’s board of directors is diverse. More than 42% of GreenLight Bio’s board is racially and ethnically diverse—a percentage double that of the S&P 500’s 21%.[1] Additionally, 30% of our non-executive directors are women and 5 of the 7 members of our board represent members of the Asian-American, Mexican-American, Black/African American, and LGBTQ+ communities.
• We are committed to ensuring best practices are followed when it comes to fair business arrangements with our partners and suppliers, specifically highlighting our priority of ensuring favorable arrangements for low- and middle-income partners.

Awards Forward Fooding’s FoodTech 500 list ranked GreenLight at #71. Described as “the world’s first definitive list of the global entrepreneurial talent at the intersection between food, technology, and sustainability,” the award recognizes GreenLight for commitment to three UN SDGs sustainable development goals (SDGs):

• zero hunger
• responsible consumption and production
• sustainable life on land

The Boston Globe ranked GreenLight as 24th of 40 Top Places to Work in Massachusetts in the 2021 large company category from an employee-based survey.We were also recognized with a cultural excellence award for our diversity, equity, and inclusion practices

‍